Synthesis of tritiated (RS)-2-amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid (AMAA), a potent and selective NMDA agonist
β Scribed by Tommy N. Johansen; Venkataraman Balasubramanian; Ulf Madsen; John W. Ferkany; Povl Krogsgaard-Larsen
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 329 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
RS)-2-Amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid (AMAA) is a potent and selective agonist at the NMDA subgroup of excitatory amino acid receptors. To probe its interaction with these receptors we have developed a synthesis of [3H]AMAA. Bromination of a protected form of AMAA with NBS followed by hydrogenolysis with tritium gas in the presence of P d C and subsequent deprotection gave [ 3H]AMAA with a specific activity of 25 Cilmmol. Attempts to develop a receptor binding assay based on rat brain homogenates and using [ 3H]AMAA as radioligand for the NMDA receptors have not been successful.
π SIMILAR VOLUMES
We have previously shown that (RS)-2-amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]propionic acid (2-Me-Tet-AMPA) is a selective agonist at (RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors, markedly more potent than AMPA itself, whereas the isomeric com